BOONTON, N.J.--(BUSINESS WIRE)--Unigene Laboratories, Inc. (OTCBB: UGNE, http://www.unigene.com) has reported that the U.S. District Court, Southern District of New York, has confirmed the validity of Unigene’s patent on Fortical® and issued an order permanently enjoining Apotex Inc. and Apotex Corp. from further infringement of the patent. The motion of the plaintiffs, Unigene and its licensee Upsher-Smith Laboratories, for summary judgment in the case was granted while the request for summary judgment by Apotex was denied.
